<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>中国证监会行政处罚决定书（李铁军）</title>
<style>
.topLine{
	height:6px;
	overflow:hidden;
	border-top:4px solid #F32F30;
	border-bottom:1px solid #F32F30;
}
.docTitle{
	font-weight:bold;
	font-size:18px;
	color:#F32F30;
	white-space:nowrap;
	text-align:center;
	margin:20px 0px 30px;
}
</style>
<style id="MyStyle">
.content P,.content Table , .content TD,.content SPAN{
	TEXT-DECORATION: none;
	word-break:break-all !important;
	word-wrap:break-word !important;
	font-family:楷体
}
.content Table{
	table-layout:auto;
}
.separator{
	color:#F32F30;
	BORDER-BOTTOM-STYLE: dotted; BORDER-LEFT-STYLE: dotted; BORDER-RIGHT-STYLE: dotted; BORDER-TOP-STYLE: dotted;
	font-weight:none;
	display:none;
}
.appendix{
	display:none;
}
.contentss{
	overflow-x:auto;width:920px;padding-bottom:30px
}
</style>
<link href="../../css/detail.css" rel="stylesheet" media="screen" type="text/css">
<link href="../../css/print.css" rel="stylesheet" media="print" type="text/css">
<style media="print">
.contentss{
	overflow-x:auto;width:650px;padding-bottom:30px
}
</style>
</head>

<body>
<div class="container" id="gkml" style="margin:0px auto;">
    <div class="header"><IMG SRC="../../images/logo.jpg" width="984"></div>
    <div class="main">
        <!--div class="rowOfCurrentPosition">
            当前位置：文体综合类 &gt; 通知公告公示123
        </div-->
		<div class="headInfo" style="position:relative;">
		<table border=0 cellspacing=0 cellpadding=0 style="width:90%;" id="headContainer">
		<tbody>
			<tr>
				<td colspan="2">
					<table border=0 cellspacing=0 cellpadding=0>
						<tr>
							<td width="50%"><B>索 引 号:</B>40000895X/</td>
							<td>
								<B>分类:</B>
								<span id="lSubcat">行政处罚&nbsp;;&nbsp;行政处罚决定</span>
							</td>
						</tr>
					</table>				
				</td>
			</tr>
			<tr>
				<td colspan="2">
					<table border=0 cellspacing=0 cellpadding=0>
						<tr>
							<td width="50%">
								<B>发布机构:</B> 
								<span>证监会</span>							
							</td>
							<td>
								<B>发文日期:</B>
								<span>2017年02月03日</span>								
							</td>
						</tr>
					</table>				
				</td>
			</tr>
			<tr>
				<td colspan="2">
					<B>名　　称:</B> 
					<span id="lTitle">中国证监会行政处罚决定书（李铁军）</span>
		            
				</td>
			</tr>
			<tr>
				<td colspan="2">
					<table border=0 cellspacing=0 cellpadding=0>
						<tr>
							<td width="50%">
								<B>文　　号:</B> 
								<span>〔2017〕17号</span>					           
							</td>
							<td>
								<B>主 题 词:</B> 
								<span></span>								
							</td>
						</tr>
					</table>				
				</td>
			</tr>
			<!--<tr>
				<td colspan="2">
				<b>内容提要:</b>
				</td>
			</tr>
			<tr>
				<td colspan="2">
					<span></span>					
				</td>
			</tr>-->
		</tbody>
		</table>
		</div>        
	<OBJECT   id="WebBrowser"   classid="CLSID:8856F961-340A-11D0-A96B-00C04FD705A2"   height="0"   width="0"></OBJECT> 	
        <div class="mainContainer" >
			<div STYLE=" width:800px">
				<p align="center"><br><font size="1" style="FONT-SIZE: 18pt; COLOR: red; FONT-FAMILY: 黑体"><strong>
				<script>
				var strssre="中国证监会行政处罚决定书（李铁军）";
				if(strssre.length>32)
				{
					if(strssre.length<50)
					{
						document.writeln(strssre.substring(0,25)+"<br/>");
						document.writeln(strssre.substring(25,strssre.length));
					}
					else if(strssre.length<67)
					{
						document.writeln(strssre.substring(0,25)+"<br/>");
						document.writeln(strssre.substring(25,49)+"<br/>");
						document.writeln(strssre.substring(49,strssre.length));
					}
					else
					{
						document.writeln(strssre.substring(0,25)+"<br/>");
						document.writeln(strssre.substring(25,49)+"<br/>");
						document.writeln(strssre.substring(49,70)+"<br/>");
						document.writeln(strssre.substring(70,strssre.length));
					}
				}
				else
				{
					document.writeln(strssre);
				}
				</script>
				</strong></font><br/><br/>
				<!--
				<font face="楷体_GB2312">〔2017〕17号</font><br>
				--></p>
			</div>

			
			<div class="contentss"  id="ContentRegion">				
				<div class="content"><P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; COLOR: rgb(0,0,0); FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LINE-HEIGHT: 150%; TEXT-ALIGN: center"><SPAN style="FONT-SIZE: 10.5pt; COLOR: rgb(0,0,0); FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">〔2017〕17号</SPAN><SPAN style="FONT-SIZE: 10.5pt; COLOR: rgb(0,0,0); FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LAYOUT-GRID-MODE: char; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; COLOR: rgb(0,0,0); FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p>&nbsp;</o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">当事人：李铁军，男，1960年5月生，住址：吉林省集安市。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">依据《中华人民共和国证券法》（以下简称《证券法》）的有关规定，我会对李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕交易</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">吉林省集安益盛药业股份有限公司</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（以下简称益盛药业）股票行为</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">进行了调查，并依法向当事人告知了作出行政处罚的违法事实、理由、依据及当事人依法享有的权利。当事人未陈述、申辩，也未要求听证。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">本案现已调查、审理终结。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p15 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">经查明，李铁军存在的违法事实如下:</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">一、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕信息</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">的</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">形成</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">和</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">公开过程</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（一）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">筹划</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">发行股份购买资产</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">相关</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕信息</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">的形成和公开过程</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">经前期沟通和考察，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年10月底，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">抚松长白山人参市场投资发展有限公司（该公司住所位于吉林省抚松县万良镇万福村，以下简称</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万良人参市场</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">实际控制人</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">杨某宇等拜访</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业，介绍了万良人参市场，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">并</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">重点介绍了万良人参市场正在争取</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">人参中药材质量可</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">追溯认证体系</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">资质及</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">人参交易专营许可资质。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业董事长张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">对</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">此很感兴趣，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">表示可以考虑收购万良人参市场100%股权。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年11月20日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">召集</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军、王某、毕某涛</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">薛某民</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">等人开会商议与万良人参市场合作事宜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">会议议定：益盛药业拟通过发行股份收购万良人参市场100%股权，价格待调查评估后定。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年11月22日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">杨某宇等</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">与</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军及中介机构人员开会，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">进一步</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">洽谈</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">合作</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">事宜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。23日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">至</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">26日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">带领</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">中介机构人员前往</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万良人参市场进行初步尽职调查。2013年11月底，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万良人参市场杨某宇</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">某</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">香再次</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">前往益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，称万良人参市场正在积极争取承担</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">人参质量可</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">追溯认证体系建设项目</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万良人参市场方面</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">正</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">着手办理手续，益盛</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">药业方面可</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">等待结果。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年3月29日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜得知</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万良人参市场的人参</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">质量</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">可追溯认证体系资质已办</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">妥</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">次日，张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某携</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">中介机构</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">人员与万良人参市场于某香等人</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">会面，双方签订了合作意向书，确定益盛药业向万良人参市场股东定向发行股份收购万良人参市场100%股权。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年4月1日，益盛药业发布停牌公告，称正在筹划发行股份购买资产</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">并</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">于2014年3月31日开市起临时停牌。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">后双方</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">合作</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">因故</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">终止</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业未公告收购万良人参市场的具体情况。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">在考虑收购万良人参市场期间，张某胜曾与</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">长白山皇封参业有限公司（以下简称皇封参业）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">洽谈</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">收购</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">,并</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">提出了初步合作</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">意向</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">及收购方式。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">与万良人参市场终止合作后，益盛药业于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">5</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">月</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">与</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">皇封参业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">方面启动收购洽谈，并于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年6月27日发布《关于发行股份及支付现金购买资产并募集配套资金的一般风险提示暨复牌公告》，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">称</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">拟发行股份及支付现金购买皇封参业100%股权。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">后因双方</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">存在分歧，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">收购</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">终止。2014年10月25日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">发布公告称2014年10月24日召开董事会审议通过了《关于终止发行股份及支付现金购买资产事项的议案》。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">我会认为，益盛药业拟发行股份购买资产的事项属于公司重大的购置财产的决定，构成</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">《证券法》</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">第六十七条第（二）项规定的重大事件；</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">同时，为购买资产发行股份筹集资金还属于公司发行新股的行为，属于公司增资的计划。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">在益盛药业发布公告前，该信息属于《</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证券法</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">》第</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">七十五条第二款</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">第（一）项和第</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（二）项规定的内幕信息。该</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕信息</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">不晚于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年11月20日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">形成，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年4月1日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">公开。李铁军不晚于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年11月20日知悉该内幕信息</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，属于内幕信息知情人</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（二）益盛药业2013年度利润分配方案相关内幕信息的形成和公开过程</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年12月中旬，益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">预测</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">全年未经审计的利润在8600</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">万元至</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">9600万元之间。2014年1月10日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">和</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">毕某涛</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">向</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">汇报</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">年利润情况，并</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">建议考虑向股东分配利润</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">表示同意，并提议</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">同时进行“高送转”。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">一两天</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">后</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">和</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">毕某涛</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">向</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜建议</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">每10股</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">支付</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">1元</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">现金股利，并建议以</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">资本公积金</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">按</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">每10股转增5股</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">的方案</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">转增股本。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">张某胜表示</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">同意，并要求</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">组织召开董事会讨论。2014年4月4日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，益盛药业年度报告</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">审计工作完成，当日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">将</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">年度报告</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">和利润分配方案发给全体董事</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">4月7日，董事会审议通过了2013年年度利润分配方案。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年4月9日，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">发布公告称</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">公司</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">董事会审议通过了《关于2013年度利润分配方案的议案》，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">将</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">向全体股东每10股派发现金股利1.00元人民币（含税），同时进行资本公积金转增股本，每10股转增5股。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">我会认为，在益盛药业发布公告前，其</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2013年度利润分配方案</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">属于《</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证券法</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">》第</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">七十五</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">条第二款</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">第（二）项规定的内幕信息。该内</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">幕信息</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">不晚于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年1月</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">10</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">日形成，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年4月9日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">公开。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">于</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2014年1月10日</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">知悉</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">该内幕信息，属于内幕信息知情人</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">二、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">控制“王某胜”“王某”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户内幕交易</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">一</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军实际控制“王某胜”“王某”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-STYLE: normal; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业上市前</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-STYLE: normal; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">至我会调查时长期</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-STYLE: normal; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">存在</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-STYLE: normal; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">委托持股的情形（另案处理）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-STYLE: normal; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">受托持股的</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">股东为</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某胜</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">尚某媛</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某、刘某明。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2012年3月</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">相关</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">股份限售解禁，代持股东会议授权</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">时任董事会秘书</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军负责对代持股份进行减持，由</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证券部具体操作。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某胜等</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">4人</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">将</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证券账户交给</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业证券部的李某</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李某</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">立即修改了密码，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">除</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军和证券事务代表</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">丁某君</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">外，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李某</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">未将修改后的密码告知任何人。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">管理前述账户期间，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李铁军</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">实际支配账户内资金，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">在代持股东未授权且不知情的情况下，授意</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">李某以相关</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">减持</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">所获</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">资金</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">从事营利活动。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">此外，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2012年1月1日至2014年3月31日期间，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“王某胜”“王某”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户交易使用的电脑高度</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">重合，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">主要</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">由李某在益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证券部</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">办公室操作</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">下单。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">（</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">二）</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“王某胜”“王某”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户在</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕信息公开前大量</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">买入</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">内幕信息公开前，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某胜”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户买入</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“益盛药业”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">910,396股</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">。卖出后实际</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">获利4,289,617.90元。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">“</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">王某</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">”</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">账户2014年1月21日买入5,000股“益盛药业”，卖出后实际获利155,942.80元。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">以上事实，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">有</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">相关人员</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">询问笔录</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、相关人员</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">通话记录</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、益盛药业</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">相关公告</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">和会议记录、</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">代持股份管理专题会议情况说明</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">、相关账户交易数据和银行资料</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">等</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">证据在案证明，足以认定。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">根据当事人违法行为的事实、性质、情节与社会危害程度，</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">依据</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">《证券法》第二百零二条</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">的</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">规定，我会决定</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">：</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">没收李铁军违法所得</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">4,44</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">5,</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">56</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">0.</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">7</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">元，并处以罚款</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">13,336,682</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">.</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">1</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">元。</SPAN><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p15 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; TEXT-INDENT: 21pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"><SPAN style="FONT-WEIGHT: normal; FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">上述当事人应自收到本处罚决定书之日起15日内，将罚没款汇交中国证券监督管理委员会（开户银行：中信银行总行营业部，账号：7111010189800000162，由该行直接上缴国库），并将注有当事人名称的付款凭证复印件送中国证券监督管理委员会稽查局备案。当事人如果对本处罚决定不服，可在收到本处罚决定书之日起60日内向中国证券监督管理委员会申请行政复议，也可在收到本处罚决定书之日起6个月内直接向有管辖权的人民法院提起行政诉讼。复议和诉讼期间，上述决定不停止执行。</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p>&nbsp;</o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p>&nbsp;</o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p>&nbsp;</o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LAYOUT-GRID-MODE: char; LINE-HEIGHT: 150%"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p>&nbsp;</o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; LAYOUT-GRID-MODE: char; WORD-BREAK: break-all; LINE-HEIGHT: 150%; TEXT-ALIGN: right"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">中国证监会</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">　&nbsp;</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">　</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">　　&nbsp;</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P>
<P class=p0 style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; WORD-BREAK: break-all; LINE-HEIGHT: 150%; TEXT-ALIGN: right"><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">2017年2月3日</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'">　　　　</SPAN><SPAN style="FONT-SIZE: 10.5pt; FONT-FAMILY: '宋体'; mso-spacerun: 'yes'"><o:p></o:p></SPAN></P><!--EndFragment--></div></br>	
			</div>

			<div class="content">					
						
			</div>
			
			<div class="noprint" style="width:100%;overflow:hidden;border-bottom:1px solid gray;margin:8px 40px"></div>

			<div class="noprint" style="text-align:center;margin:8px 0px">
				<table style="font-size:12px">
				 <!--<td>
				  【字体：<a href="#" onclick="setSize('24px');" class="navy">大</a> <a href="#" onclick="setSize('16px');" class="navy">中</a> <a href="#" onclick="setSize('12px');" class="navy">小</a>】</td>
				<td align="right" width="10"></td>-->
				<td width="60">&nbsp;</td>
				<td width="80"><a href="#" onclick="document.all.WebBrowser.ExecWB(4,1)"><img src="/pub/images/save.gif" border=0></a></td>
				<td width="80"><a href="#" onclick="javascript:window.print()"><img src="/pub/images/openpage.gif" border=0></a></td>
				<td width="80"><a href="#" onclick="window.close()"><img src="/pub/images/close.gif" border=0></a></td>
				</tr>
				</table>
			</div>
		</div>
        <div class="bottomLine"></div>
    </div>
    <div class="footer">
        <div class="footerLine"></div>
        <div><a href="/pub/newsite/fzlm/gywm/" target=_blank>关于我们</a>&nbsp;-&nbsp;<a href="/pub/newsite/fzlm/flsm/" target=_blank>法律声明</a>&nbsp;-&nbsp;<a href="/pub/newsite/fzlm/lxwm/" target=_blank>联系我们</a></div>
<div>版权所有：中国证券监督管理委员会     京ICP备 05035542号</div>
          <div>地址：北京市西城区金融大街19号富凯大厦A座  邮编：100033</div>
        <div>建议使用IE5.5以上浏览器，分辨率1024*768</div>
    </div>
</div>
</body>
</html>
./t20170207_310360_ext.json